Breakthrough Discovery: The bat coronavirus that can infect human cells through ACE2
- Probiotics may promote tumor progression?
- Taiwan Professor: Big data confirms that the COVID-19 vaccine is ineffective
- Why are the majority of Monkeypox infected people who have sex with men (MSM)?
- Experimental treatment improves skin cancer survival by 25%
- People who get flu vaccine are 40% less likely to develop Alzheimer’s disease
- Depriving women of the right to abortion is a setback for medical health and society
Breakthrough Discovery: The bat coronavirus that can infect human cells through ACE2
- How long can the patient live after heart stent surgery?
- More than 500 new drugs for blood diseases are in development
- Keytruda: The 5-year survival rate for advanced lung cancer doubled!
- Amylyx released the latest statistical analysis of new ALS drugs after being opposed by FDA panel last month
- Celine Dion is paralyzed due to muscle cramps: What are Muscle Cramps?
- Taiwan death from COVID-19 vaccination exceeds death from COVID-19
- The world top 5 best-selling drugs in 2020
Breakthrough Discovery: The bat coronavirus that can infect human cells through ACE2.
Nature: A new breakthrough in the traceability of COVID-19, the discovery of a bat coronavirus that can infect human cells through ACE2.
The COVID-19 pandemic has been going on for more than two years, causing hundreds of millions of infections and hundreds of deaths around the world. However, the origin of the new coronavirus (SARS-CoV-2) has sparked heated debate and remains unclear. Although many virologists assert that the most likely origin of the new coronavirus is bats , there is still a lack of substantive evidence.
On February 16, 2022, Marc Eloit of the Pasteur Institute in France and others published a research paper entitled: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells in the journal Nature .
The research team discovered a coronavirus with a genome similar to the new coronavirus in bats in a karst limestone cave in northern Laos , and the coronavirus can infect human cells . The finding supports the hypothesis that the new coronavirus may have originated in bats in limestone caves in or near Southeast Asia .
Previously, a variety of coronaviruses related to SARS-CoV-2 have been found in Asian horseshoe bats.
However, it has not been found in bats that are genomically close to SARS-CoV- 2 and can pass the ACE2 receptor.
SARS-CoV progenitor virus that infects human cells, and such viruses will be the key to unraveling the origin of the new coronavirus.
In this Nature paper, the research team examined 645 bats (46 species of bats belonging to 6 families) living in limestone caves in northern Laos and found 3 coronaviruses closely related to SARS-CoV-2. Virus.
Their receptor binding domain (RBD) differs from the new coronavirus receptor binding domain (RBD) by only one or two amino acid residues at the binding interface with ACE2 .
More importantly, compared with the SARS-CoV-2 strains isolated at the beginning of the COVID-19 outbreak, these newly discovered coronaviruses bind the human ACE2 protein more efficiently , and can enter human cells and in cells by recognizing ACE2. replication, and this process can be inhibited by SARS-CoV-2 neutralizing antibodies.
Moreover, none of these coronaviruses contain a furin cleavage site in their spike proteins.
Overall, this study identified new bat coronaviruses in limestone caves in the back of Laos, which are related to the new coronavirus (SARS-CoV-2) and are able to enter human cells through human ACE2, and in human cells replicate and therefore have the potential to infect humans.
The discovery of these viruses provides key evidence for understanding the origin of the new coronavirus, suggesting that the new coronavirus (SARS-CoV-2) likely originated in bats in limestone caves in or near Southeast Asia.
Reference :
https://www.nature.com/articles/s41586-022-04532-4
Breakthrough Discovery: The bat coronavirus that can infect human cells through ACE2
(source:internet, reference only)
Disclaimer of medicaltrend.org